Literature DB >> 28427761

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).

M Mañós1, J Giralt2, A Rueda3, J Cabrera4, J Martinez-Trufero5, J Marruecos6, A Lopez-Pousa7, J P Rodrigo8, B Castelo9, J Martínez-Galán10, F Arias11, M Chaves12, J J Herranz13, V Arrazubi14, N Baste2, A Castro9, R Mesía15.   

Abstract

Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific multimodality therapy, up to half of the patients will develop recurrence. Treatment selection based on a multidisciplinary tumor board represents the cornerstone of head and neck cancer, as it is essential for achieving the best results, not only in terms of outcome, but also in terms of organ-function preservation and quality of life. Evidence-based international and national clinical practice guidelines for head and neck cancer not always provide answers in terms of decision-making that specialists must deal with in their daily practice. This is the first Expert Consensus on the Multidisciplinary Approach for Head and Neck Squamous Cell Carcinoma (HNSCC) elaborated by the Spanish Society for Head and Neck Cancer and based on a Delphi methodology. It offers several specific recommendations based on the available evidence and the expertise of our specialists to facilitate decision-making of all health-care specialists involved.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Clinical guidelines; Delphi methodology; Head and neck cancer; Spanish multidisciplinary consensus

Mesh:

Year:  2017        PMID: 28427761     DOI: 10.1016/j.oraloncology.2017.04.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.

Authors:  A Fondevilla Soler; J L López-Guerra; A García Fernández; M A Samaniego Conde; M J Belmonte González; J M Praena-Fernandez; E Rivin Del Campo; M Alcaraz; I Azinovic
Journal:  Clin Transl Oncol       Date:  2018-11-30       Impact factor: 3.405

Review 2.  Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management.

Authors:  Rossana Berardi; Francesca Morgese; Silvia Rinaldi; Mariangela Torniai; Giulia Mentrasti; Laura Scortichini; Riccardo Giampieri
Journal:  Cancer Manag Res       Date:  2020-09-30       Impact factor: 3.989

3.  Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain.

Authors:  Virginia Arrazubi; Gerardo Cajaraville; David Cantero; Jordi Giralt; Ricard Mesia; Florencio Monje; Antonio Rueda; Alexander Sistiaga; Jorge Suarez; Alejandro Mut; Marta Comellas; Luis Lizán
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

4.  Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.

Authors:  Juan A Marín-Jiménez; Marc Oliva; Paloma Peinado Martín; Santiago Cabezas-Camarero; Maria Plana Serrahima; Gonzalo Vázquez Masedo; Alicia Lozano Borbalas; María N Cabrera Martín; Anna Esteve; María C Iglesias Moreno; Esther Vilajosana Altamis; Lorena Arribas Hortigüela; Miren Taberna Sanz; Pedro Pérez-Segura; Ricard Mesía
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

5.  A novel larynx-preserving pharyngectomy technique using a thyroid gland flap after chemoradiotherapy.

Authors:  Tetsuya Ogawa; Hiroki Okamoto; Daisuke Inukai; Rui Sano; Nobuyuki Katahira; Syunpei Yamanaka; Kinga Yo; Taichi Kan; Hiromi Ueda
Journal:  Clin Case Rep       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.